Endocrinology, Vol 117, 2211-2217, Copyright © 1985 by Endocrine Society

ARTICLES

Dexamethasone stimulates osteogenesis in chick periosteum in vitro

HC Tenenbaum and JN Heersche

Folded periosteal explants derived from 16-day-old chick embryo calvariae differentiate and form bone when cultured for 6 days in chemically defined, hormone-supplemented medium or on plasma clots. We studied the effect of dexamethasone on generation of cells with osteoblastic phenotype in such cultures. Bone cell phenotype was evaluated by determination of alkaline phosphatase (AP) activity. Cellular proliferation was assessed by measuring ornithine decarboxylase (ODC) activity, [3H]thymidine uptake, and radioautography of cultures that had incorporated [3H]thymidine. Cultures were exposed to various medium concentrations of dexamethasone (10(-6) M, 10(-7) M, 10(-8) M) from the outset or from the second or fourth day of culture onwards. In cultures continuously exposed to dexamethasone and maintained in chemically defined media or on plasma clots, dexamethasone increased AP activity measured at day 6. This effect was maximal at 10(-7) M dexamethasone. Cultures exposed to dexamethasone after day 2 in culture also showed increased AP activity, but only in the cultures maintained on plasma clots. There was no stimulation of AP activity when dexamethasone was added at day 4 of culture with either medium, thus suggesting that the effect of glucocorticoids depends on the stage of differentiation of the cultures. In addition to AP stimulation, dexamethasone also stimulated ODC activity. Since ODC activity has been associated with mesenchymal cell proliferation, this suggested that dexamethasone stimulated the proliferation of similar cells in the cultured periostea. Measuring [3H]thymidine uptake in and performing autoradiography of control cultures and cultures treated with dexamethasone confirmed that stimulation of proliferation did occur and located this proliferation within the cell layer adjacent to the bone surface. These results demonstrate that dexamethasone stimulates in vitro osteogenesis, and that this effect appears to be mediated through stimulation of progenitor cell proliferation. In addition, our data indicate that factors in the clot medium modulate the responsiveness of the precursor cell population.

This article has been cited by other articles:

				J. E. Phillips, C. A. Gersbach, A. M. Wojtowicz, and A. J. Garcia Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation J. Cell Sci., February 1, 2006; 119(3): 581 - 591. [Abstract] [Full Text] [PDF]

				R. Ikeda, K. Yoshida, S. Tsukahara, Y. Sakamoto, H. Tanaka, K.-I. Furukawa, and I. Inoue The Promyelotic Leukemia Zinc Finger Promotes Osteoblastic Differentiation of Human Mesenchymal Stem Cells as an Upstream Regulator of CBFA1 J. Biol. Chem., March 4, 2005; 280(9): 8523 - 8530. [Abstract] [Full Text] [PDF]

				L. B. Sher, H. W. Woitge, D. J. Adams, G. A. Gronowicz, Z. Krozowski, J. R. Harrison, and B. E. Kream Transgenic Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Osteoblasts Reveals an Anabolic Role for Endogenous Glucocorticoids in Bone Endocrinology, February 1, 2004; 145(2): 922 - 929. [Abstract] [Full Text] [PDF]

				C. A. Luppen, N. Leclerc, T. Noh, A. Barski, A. Khokhar, A. L. Boskey, E. Smith, and B. Frenkel Brief Bone Morphogenetic Protein 2 Treatment of Glucocorticoid-inhibited MC3T3-E1 Osteoblasts Rescues Commitment-associated Cell Cycle and Mineralization without Alteration of Runx2 J. Biol. Chem., November 7, 2003; 278(45): 44995 - 45003. [Abstract] [Full Text] [PDF]

				A. Yamaguchi, T. Komori, and T. Suda Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1 Endocr. Rev., August 1, 2000; 21(4): 393 - 411. [Abstract] [Full Text] [PDF]

				K. Mori, A. Shioi, S. Jono, Y. Nishizawa, and H. Morii Dexamethasone Enhances In Vitro Vascular Calcification by Promoting Osteoblastic Differentiation of Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2112 - 2118. [Abstract] [Full Text] [PDF]

				P. C. Fritz, W. E. Ward, S. A. Atkinson, and H. C. Tenenbaum Tamoxifen Attenuates the Effects of Exogenous Glucocorticoid on Bone Formation and Growth in Piglets Endocrinology, August 1, 1998; 139(8): 3399 - 3403. [Abstract] [Full Text] [PDF]

				S. D. Boden, G. Hair, L. Titus, M. Racine, K. McCuaig, J. M. Wozney, and M. S. Nanes Glucocorticoid-Induced Differentiation of Fetal Rat Calvarial Osteoblasts Is Mediated by Bone Morphogenetic Protein-6 Endocrinology, July 1, 1997; 138(7): 2820 - 2828. [Abstract] [Full Text] [PDF]